Reliable Reportable Data With Analytical Quality By Design Approaches

By Ian Edwards M.Sc. Ph.D., Manager, Global Pharmaceutical Segment Marketing

There’s a significant paradigm shift and it’s drastically changing the way pharmaceutical organizations and their partners achieve reliable, reportable data. The route to drug approval requires a multitude of underlying activities and factors which, if not managed carefully, can have a devastating business impact. While still important, regulatory compliance alone is simply not enough to be able to make critical drug product related decisions.

In this blog we discuss how leveraging modern analytical tools and applying an Analytical Quality by Design approach in your lab can increase the robustness of analytical methods.